New Study Suggests Appropriate Low-Dose Aspirin Use Could Save Millions in Costs

Appropriate use of low-dose aspirin for primary and secondary cardiovascular event prevention could improve patient outcomes with significant cost savings to payers, according to a recent study published in the Journal of Managed Care & Specialty Pharmacy. The study compared current rates of aspirin use to appropriate guideline-recommended aspirin use and found that aspirin is underused in the U.S. It suggests that clinical evidence-based, guideline-compliant use of aspirin for primary and secondary cardiovascular event prevention would result in $4.2 million and $11 million, respectively, in cost savings for a hypothetical 1-million-member plan over a five-year period. The charts below detail estimated savings and medical events for the hypothetical population.

SOURCE: Journal of Managed Care & Specialty Pharmacy. 2018;24(11):1102-11. Visit https://www.jmcp.org/doi/full/10.18553/jmcp.2018.24.11.1102.